These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Primary lung metastases in pediatric malignant non-Wilms renal tumors: data from SIOP 93-01/GPOH and SIOP 2001/GPOH. Warmann SW; Nourkami N; Frühwald M; Leuschner I; Schenk JP; Fuchs J; Graf N Klin Padiatr; 2012 Apr; 224(3):148-52. PubMed ID: 22513793 [TBL] [Abstract][Full Text] [Related]
10. Nephroblastomatosis update. Laberge JM Med Pediatr Oncol; 2003 Jul; 41(1):96-7. PubMed ID: 12764764 [No Abstract] [Full Text] [Related]
11. Cytopathology of uncommon malignant renal neoplasms in the pediatric age group. Radhika S; Bakshi A; Rajwanshi A; Nijhawan R; Das A; Kakkar N; Joshi K; Marwaha RK; Rao KL Diagn Cytopathol; 2005 May; 32(5):281-6. PubMed ID: 15830360 [TBL] [Abstract][Full Text] [Related]
12. Malignant rhabdoid tumor of the kidney: significantly improved response to pre-operative treatment intensified with doxorubicin. Furtwängler R; Nourkami-Tutdibi N; Leuschner I; Vokuhl C; Niggli F; Kager L; Ebinger M; Frühwald MC; Graf N; Cancer Genet; 2014 Sep; 207(9):434-6. PubMed ID: 25242089 [TBL] [Abstract][Full Text] [Related]
13. Ovarian sarcoma with pathologic features of clear cell sarcoma of the kidney. Finn LS; Patterson K Pediatr Dev Pathol; 2000; 3(5):487-91. PubMed ID: 10890934 [TBL] [Abstract][Full Text] [Related]
14. Management decisions in children with nephroblastomatosis. Prasil P; Laberge JM; Bond M; Bernstein M; Pippi-Salle JL; Bernard C; Patenaude Y Med Pediatr Oncol; 2000 Oct; 35(4):429-32; discussion 433. PubMed ID: 11025476 [No Abstract] [Full Text] [Related]
15. Evaluation of CITED1, SIX1, and CD56 protein expression for identification of blastemal elements in Wilms tumor. Sehic D; Ciornei CD; Gisselsson D Am J Clin Pathol; 2014 Jun; 141(6):828-33. PubMed ID: 24838327 [TBL] [Abstract][Full Text] [Related]
16. [Wilms' tumour of unfavorable histology--results of treatment with the SIOP 93-01 protocol at the Gdańsk centre. Preliminary report]. Stefanowicz J; Sierota D; Balcerska A; Stoba C Med Wieku Rozwoj; 2004; 8(2 Pt 1):197-200. PubMed ID: 15738594 [TBL] [Abstract][Full Text] [Related]
18. Effect of duration of treatment on treatment outcome for patients with clear-cell sarcoma of the kidney: a report from the National Wilms' Tumor Study Group. Seibel NL; Li S; Breslow NE; Beckwith JB; Green DM; Haase GM; Ritchey ML; Thomas PR; Grundy PE; Finklestein JZ; Kim T; Shochat SJ; Kelalis PP; D'Angio GJ J Clin Oncol; 2004 Feb; 22(3):468-73. PubMed ID: 14752069 [TBL] [Abstract][Full Text] [Related]
19. Diffuse and strong cyclin D1 immunoreactivity in clear cell sarcoma of the kidney. Mirkovic J; Calicchio M; Fletcher CD; Perez-Atayde AR Histopathology; 2015 Sep; 67(3):306-12. PubMed ID: 25556515 [TBL] [Abstract][Full Text] [Related]
20. The cytological diagnosis of paediatric renal tumours. Shet T; Viswanathan S J Clin Pathol; 2009 Nov; 62(11):961-9. PubMed ID: 19700411 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]